Patients with BRCA mutations have superior outcomes after intraperitoneal chemotherapy in optimally resected high grade ovarian cancer

R. Wendel Naumann, Jacob C. Morris, David L. Tait, Robert V. Higgins, Erin K. Crane, Lane K. Drury, Lisa Amacker-North, Megan Templin, Jubilee Brown

Research output: Contribution to journal › Article › peer-review

24 Scopus citations

Fingerprint

Dive into the research topics of 'Patients with BRCA mutations have superior outcomes after intraperitoneal chemotherapy in optimally resected high grade ovarian cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences